Hydroxamic acids: Proton donor and acceptor strength for use in drug design

Journal of Pharmaceutical and Biomedical Analysis

Volumn 33, Issue 4, 2003, Pages 783-788

  Vanjari, Harsha ^a   Pande, Rama ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Hydroxamic acids; Proton donor and acceptor strength

Indexed keywords

FUNCTIONAL GROUP; HYDROXAMIC ACID DERIVATIVE; NITROGEN; OXYGEN;

ARTICLE; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG SYNTHESIS; HYDROGEN BOND; MEASUREMENT; PRIORITY JOURNAL; PROTON TRANSPORT; STRUCTURE ACTIVITY RELATION;

EID: 0242625962     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00282-6     Document Type: Article

References (26)

1. Neilands J.B. Science. 156:1967;1443-1447.
2. Taher A., Sheikh-Taha M., Koussa S., Inati A., Neeman R., Mourad F. Eur. J. Haematol. 67:2001;30-34.
3. Raetz C.R. J. Biol. Chem. 275:2000;11002-11009.
4. Holland K.P., Elford H.L., Bracchi V., Annis C.G., Schuster S.M., Chakrabarti D. Antimicrob. Agents Chemother. 42:1998;2456-2458.
5. Tabuchi K., Okubo H., Fujihira K., Tsuji S., Hara A., Kusakari J. Neurosci. Lett. 307:2001;29-32.
6. Leoni F., Zaliani A., Bertolini G., Porro G., Pagani P., Pozzi P., Dona G., Fossati G., Sozzani S., Azam T., Bufler R., Fantuzzi G., Goncharav I., Kim S.H., Pomerantz B.J., Reznikov L.L., Siegmund B., Dinarello C.A., Mascagni P. Proc. Natl. Acad. Sci. 99:2002;2995-3000.
7. Kikuchi T., Itoh F., Toyota M., Suzuki H., Yamamoto H., Fujita M., Hosokawa M., Imai K. Int. J. Cancer. 97:2002;272-277.
8. Clements J.M., Beckett R.P., Brown A., Catlin G., Labell M., Palan S., Thomas W., Whittaker M., Wood S., Salama S., Baker P.J., Rodgers H.F., Barynin V., Rice D.W., Hunter M.G. Antimicrob. Agents Chemother. 45:2001;563-570.
9. Komatsu Y., Tomizaki K.Y., Tsukamoto M., Kato T., Nishino N., Sato S., Yamori T., Tsuruo T., Furumai R., Yoshida M., Horinouchi S., Hayashi H. Cancer Res. 61:2001;4459-4466.
10. Clare B.W., Scozzafava A., Supuran C.T. J. Med. Chem. 44:2001;2253-2258.
11. Onishi H.R., Pelak B.A., Gerckens L.S., Silver L.L., Kahan F.M., Chen M.H., Patchett A.A., Galloway S.M., Hyland S.A., Anderson M.S., Raetz C.R.H. Science. 274:1996;980-982.
12. Ohta T., Shibata H., Kawamori T., Iimuro M., Sugimura T., Wakabayashi K. Biochem. Biophys. Res. Commun. 285:2001;728-733.
13. Montusohi P., Tringali G., Mirtella A., Parente L., Preziosi P., Navarra P. Eur. J. Pharmacol. 275:1995;31-37.
14. Soybir G., Koksoy F., Ekiz F., Yalcin O., Fincan K., Haklar G., Yuksel M. Pancreas. 19:1999;143-149.
15. Nicol D., Wratten S.D. Ann. Appl. Biol. 130:1997;387-396.
16. Abraham M.H., Duce P.P., Prior D.V., Barratt D.G., Morris J.J., Taylor P.J. J. Chem. Soc. Perkin Trans. II. 1989;1355-1375.
17. Leo A.J. Chem. Rev. 93:1993;1281-1305.
18. Hansch C., Blaney J.M. Jolles G., Wooldridge K.R.H. Drug Design - Fact or Fantasy. 1984;185-208 Academic Press, London.
19. Pande R., Tandon S.G. J. Chem. Eng. Data. 24:1979;72-74.
20. Pande R., Tandon S.G. Z. Anal. Chem. 296:1979;407-408.
21. Taft R.W., Berthelot M., Laurence C., Leo A.J. Chemtech. 26:1996;20-28.
22. Leo A., Hansch C., Elkins D. Chem. Rev. 71:1971;525-554.
23. Bodor N., Buchwald P. J. Phys. Chem. 101:1997;3404-3412.
24. Bondi A. J. Phys. Chem. 68:1964;441-451.
25. Edward J.T. Can. J. Chem. 76:1998;1294-1303.
26. Leo A.J., Hoekman D. Perspect. Drug Discov. Des. 18:2000;19-38.